Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPE | Q05469 | 4/20 | 0.33 |
| ▸ | MMP1 | P03956 | 1/20 | 0.31 |
| ▸ | MMP2 | P08253 | 1/20 | 0.31 |
| ▸ | MMP9 | P14780 | 1/20 | 0.31 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12346 | 0.84 | POLB (0.32) | LIPEMEN1POLBKMT2A | |
| SCHEMBL1589420 | 0.71 | LIPE (0.43) | LIPE | |
| SCHEMBL11103 | 0.69 | LIPE (0.45) | LIPE | |
| SCHEMBL11972 | 0.64 | LIPE (0.52) | LIPE | |
| SCHEMBL20684172 | 0.63 | SMN1; SMN2 (0.43) | TSHRMEN1NPC1ALDH1A1POLB | |
| SCHEMBL12193 | 0.63 | MCOLN3 (0.40) | LIPEMEN1KMT2AL3MBTL1 | |
| SCHEMBL12336 | 0.62 | TRPV1 (0.33) | LIPE | |
| SCHEMBL8244253 | 0.59 | CHKA (0.46) | TSHRMEN1NPC1ALDH1A1POLB | |
| SCHEMBL17897210 | 0.58 | ACACB (0.55) | TSHRMEN1ALDH1A1KMT2A | |
| SCHEMBL4669161 | 0.58 | PTGS1 (0.46) | TSHRMEN1ALDH1A1KMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2011045292-A1 | SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES | F. HOFFMANN-LA ROCHE AG (CH) | 2011-04-21 | — | — | WO | disclosed |